IRF2 and lip and oral cavity carcinoma: This analysis revealed that in addition to the positive control GAPDH, all oral cancers (except SCC4) upregulated the miR-155 downstream targets OLFML3, TBR1, BACH1, ZNF652, IRF2-BP2, and ZIC3.